Abstract
Tracheobronchial injuries are uncommon, occuring in as few as 0.5% of patients following injury. The incidence is highest following penetrating neck and the lowest as 2% following blunt chest injury. While commonly presenting as immediately life threatening injuries, they may present in a more occult fashion with late onset of hemoptysis, recurrent pneumonia and/or “asthma.” Management must be immediately directed to securing the airway, which may require advanced bronchoscopic skills. Subsequent repair must take into account the severity of associated injuries and exact location and degree of airway disruption.
Current Respiratory Medicine Reviews
Title:Diagnosis and Management of Trauma to the Trachea and Bronchi
Volume: 11 Issue: 1
Author(s): Katherine Peters, Jessica Thunell and Riyad Karmy-Jones
Affiliation:
Keywords: Airway, bronchus, trachea, trauma.
Abstract: Tracheobronchial injuries are uncommon, occuring in as few as 0.5% of patients following injury. The incidence is highest following penetrating neck and the lowest as 2% following blunt chest injury. While commonly presenting as immediately life threatening injuries, they may present in a more occult fashion with late onset of hemoptysis, recurrent pneumonia and/or “asthma.” Management must be immediately directed to securing the airway, which may require advanced bronchoscopic skills. Subsequent repair must take into account the severity of associated injuries and exact location and degree of airway disruption.
Export Options
About this article
Cite this article as:
Peters Katherine, Thunell Jessica and Karmy-Jones Riyad, Diagnosis and Management of Trauma to the Trachea and Bronchi, Current Respiratory Medicine Reviews 2015; 11 (1) . https://dx.doi.org/10.2174/1573398X1101150706145419
DOI https://dx.doi.org/10.2174/1573398X1101150706145419 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Xuesaitong May Protect Against Ischemic Stroke by Modulating Microglial Phenotypes and Inhibiting Neuronal Cell Apoptosis via the STAT3 Signaling Pathway
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Regulation of Glutamate Synthesis Via Inhibition of Glutamate Carboxypeptidase II (GCPII): An Effective Method to Treat Central and Peripheral Nervous System Disorders (Guest Editors: Guido Cavaletti and Barbara Slusher)]
Current Medicinal Chemistry Changing Pain Management Strategy from Opioid-centric Towards Improve Postoperative Cognitive Dysfunction with Dexmedetomidine
Current Drug Metabolism Defining the Mechanism of Action of 4-Phenylbutyrate to Develop a Small-Molecule-Based Therapy for Alzheimers Disease
Current Medicinal Chemistry Omega-3 Nutrition Therapy for the Treatment of Diabetic Sensorimotor Polyneuropathy
Current Diabetes Reviews Disorders of Consciousness and Pharmaceuticals that Act on Oxygen Based Amino Acid and Monoamine Neurotransmitter Pathways of the Brain
Current Pharmaceutical Design Fluoride Interactions: From Molecules to Disease
Current Signal Transduction Therapy Potential Roles of Selenium and Selenoproteins in the Prevention of Alzheimer's Disease
Current Topics in Medicinal Chemistry NF-κB, a Potential Therapeutic Target for the Treatment of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents
Current Medicinal Chemistry - Central Nervous System Agents Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Copper Status Abnormalities and How to Measure Them in Neurodegenerative Disorders
Recent Patents on CNS Drug Discovery (Discontinued) The Yin and Yang of Antiviral Innate Immunity in Central Nervous System
Current Pharmaceutical Design Self-Assembling Peptide Nanofibrous Scaffolds for Tissue Engineering: Novel Approaches and Strategies for Effective Functional Regeneration
Current Protein & Peptide Science Royal Jelly Acid, 10-Hydroxy-trans-2-Decenoic Acid, as a Modulator of the Innate Immune Responses
Endocrine, Metabolic & Immune Disorders - Drug Targets Mesenchymal Stem Cells in the Umbilical Cord: Phenotypic Characterization, Secretome and Applications in Central Nervous System Regenerative Medicine
Current Stem Cell Research & Therapy Potential Application of Induced Pluripotent Stem Cells in Cell Replacement Therapy for Parkinsons Disease
CNS & Neurological Disorders - Drug Targets Neurorestorative Role of Stem Cells in Alzheimer’s Disease: Astrocyte Involvement
Current Alzheimer Research Targeted Delivery of Growth Factors by HSV-Mediated Gene Transfer for Peripheral Neuropathy
Current Gene Therapy Functions of Fukutin, a Gene Responsible for Fukuyama Type Congenital Muscular Dystrophy, in Neuromuscular System and Other Somatic Organs
Central Nervous System Agents in Medicinal Chemistry